Visualitza per autor "Halperin, Daniel M"
Ara mostrant els elements 1-1 d 1
-
Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET
Singh, Simron; Ferone, Diego; Chan, Jennifer; Halperin, Daniel M; Capdevila Castillon, Jaume; de Herder, Wouter (BMC, 2024-01-16)